PMID- 29520199 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220409 IS - 1318-2099 (Print) IS - 1581-3207 (Electronic) IS - 1318-2099 (Linking) VI - 52 IP - 1 DP - 2018 Mar TI - Helicobacter Pylori Treatment Results in Slovenia in the Period 2013-2015 as a Part of European Registry on Helicobacter Pylori Management. PG - 1-6 LID - 10.1515/raon-2017-0055 [doi] AB - BACKGROUND: Helicobacter pylori (H. pylori) is the most common chronic bacterial infection in the world affecting over 50% of the world's population. H. pylori is a grade I carcinogen, responsible for the development of 89 % of noncardia gastric cancers. In the present study we analyzed the data for H. pylori eradication treatments in Slovenia. PATIENTS AND METHODS: Slovenia is a part of the European Registry on Helicobacter pylori Management from the beginning. In seven medical institutions data for H. pylori eradication treatments was collected for 1774 patients from April 16(th) 2013 to May 15(th) 2016. For further modified intention to treat (mITT) analysis 1519 patients were eligible and for per protocol (PP) analysis 1346 patients. RESULTS: Patients' dropout was 11.4%. Eradication rate for 7 day triple therapy with proton pump inhibitor (PPI) + Clarithromycin (C) + Amoxicillin (A) was 88.7% PP and 72.0% mITT; for PPI + C + Metronidazole (M) 85.2% PP and 84.4% mITT. Second line 14 day therapy PPI + A + Levofloxacin had 92.3% eradication rate PP and 87.1% mITT. Ten to fourteen day Bismuth quadruple therapy was the therapy in difficult to treat patients. At the end all patients that adhered to prescribed regimens were cured of their H. pylori infection. CONCLUSIONS: High dropout rate deserves further analysis. Slovenia is still a country with < 15% H. pylori resistance to clarithromycin, triple therapy with PPI plus two antibiotics reaches PP eradication rate > 85%, but mITT eradication rates are suboptimal. FAU - Tepes, Bojan AU - Tepes B AD - Abakus Medico, Diagnostic Center Rogaska, Rogaska Slatina, Slovenia. FAU - Kastelic, Marko AU - Kastelic M AD - Abakus Medico, Diagnostic Center Rogaska, Rogaska Slatina, Slovenia. FAU - Vujasinovic, Miroslav AU - Vujasinovic M AD - General Hospital Slovenj Gradec, Slovenj Gradec, Slovenia. FAU - Lampic, Polona AU - Lampic P AD - Diagnostic Center Bled, Bled, Slovenia. FAU - Seruga, Maja AU - Seruga M AD - General Hospital Murska Sobota, Murska Sobota, Slovenia. FAU - Jurecic, Natasa Brglez AU - Jurecic NB AD - General Hospital Trbovlje, Trbovlje, Slovenia. FAU - Nyssen, Olga P AU - Nyssen OP AD - Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigacion Sanitaria Princesa (IIS-IP) and Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Madrid, Spain. FAU - Donday, Maria G AU - Donday MG AD - Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigacion Sanitaria Princesa (IIS-IP) and Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Madrid, Spain. FAU - O'Morain, Colm AU - O'Morain C AD - Beacon Consultants Clinic, Dublin, Ireland. FAU - Megraud, Francis AU - Megraud F AD - Laboratoire de Bacteriologie-Enfants Hopital Pellegrin 33076Bordeaux cedex, France. FAU - McNicholl, Adrian G AU - McNicholl AG AD - Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigacion Sanitaria Princesa (IIS-IP) and Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Madrid, Spain. FAU - Gisbert, Javier P AU - Gisbert JP AD - Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigacion Sanitaria Princesa (IIS-IP) and Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas (CIBEREHD), Madrid, Spain. LA - eng PT - Journal Article DEP - 20171207 PL - Poland TA - Radiol Oncol JT - Radiology and oncology JID - 9317213 PMC - PMC5839075 OTO - NOTNLM OT - European Registry on Helicobacter pylori management OT - Helicobacter pylori OT - Slovenian results OT - eradication treatment COIS- Disclosure: No potential conflicts of interest were disclosed. EDAT- 2018/03/10 06:00 MHDA- 2018/03/10 06:01 PMCR- 2018/03/01 CRDT- 2018/03/10 06:00 PHST- 2017/09/11 00:00 [received] PHST- 2017/11/05 00:00 [accepted] PHST- 2018/03/10 06:00 [entrez] PHST- 2018/03/10 06:00 [pubmed] PHST- 2018/03/10 06:01 [medline] PHST- 2018/03/01 00:00 [pmc-release] AID - raon-2017-0055 [pii] AID - 10.1515/raon-2017-0055 [doi] PST - epublish SO - Radiol Oncol. 2017 Dec 7;52(1):1-6. doi: 10.1515/raon-2017-0055. eCollection 2018 Mar.